These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 227425)

  • 1. Studies on the mechanism of action of protacine (CR 604), a new non-steroidal anti-inflammatory agent.
    Vidal y Plana RR; Makovec F; Cifarelli A; Bizzarri D; Setnikar I; Rovati AL
    Arzneimittelforschung; 1979; 29(8):1122-5. PubMed ID: 227425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the safety of a new non-steroidal anti-inflammatory drug: protacine (CR 604).
    Vidal y Plana RR; Cifarelli A; Bizzarri D; Senin P; Makovec F
    Arzneimittelforschung; 1979; 29(8):1126-9. PubMed ID: 583009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604).
    Rovati AL; Vidal y Plana RR; Casula PL; Bizzarri D; Makovec F; Setnikar I
    Arzneimittelforschung; 1979; 29(8):1116-22. PubMed ID: 315235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the pharmacodynamics of acemetacin (author's transl)].
    Jacobi H; Dell HD
    Arzneimittelforschung; 1980; 30(8A):1348-62. PubMed ID: 6968219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of nonsteroidal anti-inflammatory agents on fibrinolysis and platelet aggregation].
    Lakin KM; Schipilowa SJ; Nowikowa NW; Rukasenkow JE; Pomojnezkij WD; Grenadjorow SJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):230-5. PubMed ID: 2427406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of non-steroidal antiinflammatory agents on platelet aggregation and vessel tone in relation to inhibition of PGI2- and thromboxane-release. With particular reference to 5-benzoyl-alpha-methyl-2-thiophene acetic acid (tiaprofenic acid).
    Kuhn A; Sauerland S; Schiffer K; Schrör K
    Arzneimittelforschung; 1980; 30(9):1538-42. PubMed ID: 7006618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifenagrel: a chemically novel platelet aggregation inhibitor.
    Abrahams SL; Hazen RJ; Batson AG; Phillips AP
    J Pharmacol Exp Ther; 1989 May; 249(2):359-65. PubMed ID: 2542526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of a new non-steroidal anti-inflammatory drug: flunoxaprofen.
    Lampa E; Romano AR; Berrino L; Tortora G; Di Guglielmo R; Filippelli A; Gentile B; Marmo E
    Drugs Exp Clin Res; 1985; 11(8):501-9. PubMed ID: 2942383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.
    Fleming JS; Buyniski JP; Cavanagh RL; Bierwagen ME
    J Pharmacol Exp Ther; 1975 Aug; 194(2):435-49. PubMed ID: 1151769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
    Prisco D; Bartoletti A; Lombardi A
    Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):209-13. PubMed ID: 3110512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of flupirtine on prostaglandin formation and platelet aggregation in vitro.
    Darius H; Schrör K
    Arzneimittelforschung; 1985; 35(1):55-9. PubMed ID: 3885962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary double-blind evaluation of a new, non-steroidal anti-inflammatory drug: protacine.
    Münzenberg J; Tachibana S
    Pharmatherapeutica; 1980; 2(5):279-84. PubMed ID: 7001486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo.
    Basista M; Grodzińska L; Gryglewski RJ
    Pol J Pharmacol Pharm; 1985; 37(1):41-6. PubMed ID: 3929239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dog.
    Setnikar I; Arigoni R; Chisté R; Makovec F; Revel L
    Arzneimittelforschung; 1987 Jun; 37(6):698-702. PubMed ID: 3663267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.